Rheumatologists meet in Madrid to address the latest advances in the specialty

Madrid, 18 (Survimedia)

This weekend the Spanish Rheumatological League (LIRE) is celebrating its Congress, which this year celebrates its 50th anniversary and which brings together specialists, service companies and assistance, researchers and medicine in the treatment of patients with rheumatic and musculoskeletal diseases (ERyMES). Will bring companies together.

With the motto ‘Towards a new model of care of patients with rheumatic diseases’, the President of LIRE, Ana Isabel Vázquez Lozo, explained that this congress will highlight “all the great and disruptive changes that are taking place in relation to the care of patients with rheumatic and musculoskeletal diseases , especially from the field of mental health and pain, where we have been able to verify a significant and worrying increase in suicides over the last ten years.

During the two days of the Congress, the results of the study ‘Pain and mental health in ER&MES’, carried out by LIRE, will be presented, as well as the report ‘Voice of the patient with ER&MES in Spain’, in which the health Care needs are covered. According to a study conducted by LIRE with the consulting firm Albor on 40 associations and institutions of LIRE, the resources and infrastructure for patients suffering from arthritis and musculoskeletal diseases include approximately 11,000 patients from all over Spain.

For this reason, the President of LIRE explained that at this meeting, in addition to scientific sessions and conferences, a series of workshops and workshops designed for patients and professionals on the topics of greatest interest will be organized. “We want that, in addition to the knowledge that Congressmen can gain, they can also take home key aspects, through these workshops and workshops, by being in close contact with experts.”


Loreto Carmona, Scientific Director of the Institute of Musculoskeletal Health (INMUSC) and President of Euler Advocacy, will give the inaugural conference on ‘The present and future of research’. For her part, Elisenda de la Torre, Vice-President of LIRE and President of the Catalan Rheumatological League, spoke about ‘Towards a patient experience model in ERIMES?’ Will speak about.

Three round tables were also proposed: ‘Models of patient associations in the 21st century. What role do they play in health systems and what needs do they meet in the replacement of health administration?’, ‘Challenges and opportunities of the patient experience model’, and ‘Pain and mental health in the ER&ME’.

Workshops (primarily for patients and families) and ‘workshops’ (for health professionals) will be held this Saturday and will be highly practical in nature.


The workshops scheduled are ‘Improve your quality of life through a professional’ (work disability, nutrition myths, adapted exercise and how to deal with pain), and ‘Learn about your disease through an expert’ (fibromyalgia , family) with sons and daughters with ER&ME, osteoarthritis and osteoporosis, and autoimmune diseases).

The ‘workshops’ will be ‘Pulmonary Fibrosis and Other Underdiagnosed Comorbidities’; ‘How to Live with Immune-Mediated Disease: Lupus, Dermatomyositis, Rheumatoid Arthritis, APS, etc.’; ‘Polymyalgia’; and ‘PROMS: the importance and need to collect PROMS important to patients’.

In addition, this meeting will have the support of the Spanish Confederation of People with Physical and Organic Disabilities (COSEMF), the Spanish Patients’ Forum (FEP), the Platform of Patient Organizations (POP), the European Academy of Patients (UPAATI), the School of Public Health (SPA), and the European Academy of Patients with Physical and Organic Disabilities (APPA). Madrid population of patients and caregivers, Spanish Society of Rheumatology (SER), Spanish Society of Pain (SED), Spanish Society of Pediatric Rheumatology (SARP), OpenRheuma, Spanish Society of Primary Physicians (SEMARGEN), Spanish Society General and Family Physicians (SEMG) and ONCE Foundation.

The ’50 Years LIRE Congress’ will be sponsored by Boehringer Ingelheim and the companies AbbVie, AstraZeneca, Grunenthal, Lilly, Novartis, Pfizer, Sanofi and UCB. It will also be supported by the collaboration of the Ministry of Health and the Department of Health of the Community of Madrid.

(SurviMedia)18-Nov-2023 09:44 (GMT +1)ABG/CLC

©SurviMedia. This information is the property of Servmedia. It may only be broadcast by subscribers of this news agency citing ServiceMedia as the author or source. All rights reserved. Distribution and public communication by third parties in any medium or medium is prohibited.

Source link

Leave a Comment